Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
January 20 2021 - 8:30AM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL) will
release fourth-quarter and full-year 2020 financial results and
provide 2021 guidance on Wednesday, February 17th, before the
market opens. A conference call has been scheduled to discuss this
information on Wednesday, February 17th, at 8:30 a.m. ET.
Investors will have the opportunity to listen to a live webcast
of the conference call through the Investor Relations section of
the Company's website at ir.criver.com. A replay will be accessible
through the same website.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210120005072/en/
Investor Relations Contact: Todd Spencer Corporate Vice
President, Investor Relations 781.222.6455 todd.spencer@crl.com
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Apr 2023 to Apr 2024